Mylan to introduce generic EpiPen at half price

The generic will be identical to the branded product in terms of functionality


By Marthe Fourcade
Bloomberg News

CANONSBURG, Pa. — Mylan NV, the drugmaker under fire for pricing its EpiPen emergency allergy shots at $600, said it will introduce a generic version in coming weeks that will halve the price.

The generic EpiPen will be identical to the branded product, including device functionality and drug formulation, and cost $300 per two-pack carton, Mylan said in a statement on Monday. The company also plans to continue to sell the branded version.

A nurse and her daughter demonstrate the use of an EpiPen. (Photo/Ralph Musthaler/Pittburgh Post-Gazette)
A nurse and her daughter demonstrate the use of an EpiPen. (Photo/Ralph Musthaler/Pittburgh Post-Gazette)

Mylan has attracted scrutiny for increasing the treatment’s price to about $600 for a two-pack from $57 for a single pen in 2007.

“Ensuring access to medicine is absolutely the core of Mylan’s mission,” Chief Executive Officer Heather Bresch said in the statement.

Copyright 2016 Bloomberg News

Recommended for you

Join the discussion

Copyright © 2019 EMS1.com. All rights reserved.